Covidien Ltd Company Profile (NYSE:COV)

About Covidien Ltd

Covidien Ltd logoCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Health Care Equipment & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: COV
  • CUSIP: G2554F11
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $0
  • 200 Day Moving Average: $0
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:
Companies Related to Covidien Ltd:

Analyst Ratings

Consensus Ratings for Covidien Ltd (NYSE:COV) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Covidien Ltd (NYSE:COV)
No equities research coverage for this company has been tracked by


Earnings History for Covidien Ltd (NYSE:COV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/22/2015Q115$1.05$1.12$2.72 billion$2.69 billionViewN/AView Earnings Details
11/5/2014Q414$1.02$1.15$2.69 billion$2.73 billionViewListenView Earnings Details
7/25/2014Q314$1.00$1.04$2.69 billion$2.69 billionViewListenView Earnings Details
4/25/2014Q214$0.95$0.96$2.61 billion$2.60 billionViewListenView Earnings Details
1/24/2014Q114$0.94$1.00$2.61 billion$2.64 billionViewListenView Earnings Details
11/8/2013Q413$0.90$0.91$2.56 billion$2.56 billionViewListenView Earnings Details
8/1/2013Q3 2013$0.89$0.85$2.58 billion$2.58 billionViewListenView Earnings Details
4/26/2013Q2 2013$1.09$1.12$3.12 billion$3.10 billionViewListenView Earnings Details
1/25/2013Q1 2013$1.06$1.10$3.00 billion$3.06 billionViewListenView Earnings Details
11/9/2012Q412$1.00$1.02$2.98 billion$3.00 billionViewN/AView Earnings Details
7/26/2012$1.06$1.07ViewN/AView Earnings Details
4/27/2012$1.03$1.05ViewN/AView Earnings Details
1/26/2012$1.03$1.13ViewN/AView Earnings Details
11/15/2011$1.05$1.08ViewN/AView Earnings Details
7/26/2011$0.94$1.01ViewN/AView Earnings Details
4/21/2011$0.89$0.93ViewN/AView Earnings Details
2/1/2011$0.81$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Covidien Ltd (NYSE:COV)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS


Current Dividend Information for Covidien Ltd (NYSE:COV)
Annual Dividend:$0.00
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:NaN (Based on Current Year Consensus EPS Estimate)
NaN (Based on Next Year Consensus EPS Estimate)
Track Record:8 Years of Consecutive Dividend Growth

Dividend History for Covidien Ltd (NYSE:COV)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Covidien Ltd (NYSE:COV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2014Michael SgrignariSVPSell25,795$103.48$2,669,266.60View SEC Filing  
12/3/2014Dennis H ReilleyDirectorSell10,521$101.39$1,066,724.19View SEC Filing  
11/17/2014Richard G Brown JrVPBuy5,300$94.44$500,532.00View SEC Filing  
11/7/2014Robert H BrustDirectorSell4,000$92.03$368,120.00View SEC Filing  
8/27/2014Coleman N Lannum IIIVPBuy3,338$87.23$291,173.74View SEC Filing  
8/26/2014Coleman N Lannum IIIVPBuy1,736$87.46$151,830.56View SEC Filing  
8/19/2014Coleman N Lannum IIIVPBuy1,720$87.82$151,050.40View SEC Filing  
8/18/2014Coleman N Lannum IIIVPBuy4,100$87.58$359,078.00View SEC Filing  
6/16/2014Jose E AlmeidaInsiderSell51,166$92.05$4,709,830.30View SEC Filing  
4/29/2014Brian Douglas KingVPSell15,569$70.11$1,091,542.59View SEC Filing  
3/28/2014Charles DockendorffCFOSell90,730$72.50$6,577,925.00View SEC Filing  
2/28/2014Jose AlmeidaInsiderSell50,000$72.00$3,600,000.00View SEC Filing  
2/13/2014Richard Brown, Jr.VPSell4,000$71.00$284,000.00View SEC Filing  
2/11/2014Brian Douglas KingVPSell17,946$70.00$1,256,220.00View SEC Filing  
2/11/2014Bryan HansonSVPSell32,480$69.97$2,272,625.60View SEC Filing  
1/29/2014Coleman Lannum IIIVPSell13,787$69.23$954,474.01View SEC Filing  
1/24/2014Richard Brown, Jr.VPSell4,000$70.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Covidien Ltd (NYSE:COV)
News IconTracheal Tubes and Airway Products Market Trends and Segments 2015-2025 (NYSE:COV) - February 21 at 4:16 PM
News IconVentilators Market Headed for Growth and Global Expansion by 2020 (NYSE:COV) - February 21 at 4:16 PM
News IconGlobal Hernia Repair Devices - Medical Equipment & Supplies (NYSE:COV) - February 21 at 4:16 PM logoNon-Invasive Brain Trauma Monitoring Devices Market Explores New Growth Opportunities By 2020 (NYSE:COV) - February 21 at 4:16 PM logoWhat’s Medtronic’s Plan to Use Its Increased Cash Accessibility? (NYSE:COV) - February 21 at 4:16 PM logoCovalon Technologies Ltd. :COV-CA: Earnings Analysis: Q2, 2016 By the Numbers : June 7, 2016 (NYSE:COV) - February 21 at 4:16 PM logoGabelli Funds Comments on Medtronic Plc (NYSE:COV) - February 21 at 4:16 PM
News IconGrowth Nuclear Cardiology Market : 2015 – 2021 (NYSE:COV) - February 20 at 4:10 PM
News IconWeight Loss and Weight Management Market worth $206.4 Billion by 2019 (NYSE:COV) - February 20 at 4:10 PM logoTracheal Tubes and Airway Products Market Analysis, and Forecast Report by Future Market Insights 2015-2025 (NYSE:COV) - February 20 at 4:10 PM
News IconGlobal Brain Ischemia Market Trends, Consumption, Drivers, Strategies, Applications and Competitive (NYSE:COV) - February 18 at 10:44 AM
News IconIncontinence Products Market is Expected to Gain Popularity Across the Globe : 2016 – 2022 (NYSE:COV) - February 18 at 10:44 AM logoIncontinence Products Market Is Expected to Gain Popularity Across the Globe: 2016-2022 (NYSE:COV) - February 17 at 5:46 PM
News IconState Universities Gain Immunity from IPRs (NYSE:COV) - February 17 at 5:46 PM
News IconBiocept appoints Michael Terry SVP, commercial operations (NYSE:COV) - February 16 at 11:47 AM
News IconContinuous Renal Replacement Therapy Global Market Research Methodology, Research Scope Forecast 2022 (NYSE:COV) - February 16 at 11:47 AM logoAerosol Therapy Market: Future Demand, Growth Analysis and Forecast to 2024 (NYSE:COV) - February 16 at 11:47 AM
News IconWeight Management Market Forecast And opportunities Trends, Size, Drivers 2016 – 2023 – Credence Research (NYSE:COV) - February 14 at 10:19 PM
News IconAcute Ischemic Stroke Diagnosis and Treatment Market by Diagnostic Types Forecast Upto 2020 (NYSE:COV) - February 14 at 3:10 AM logoIntracranial Pressure Monitors Market Is Expected to Generate Huge Profits by 2021 (NYSE:COV) - February 14 at 3:10 AM
News IconNon-Vascular Stents Market Growth with Worldwide Industry Analysis to 2025 (NYSE:COV) - February 14 at 3:10 AM
News IconPressure ulcers in home care settings: (NYSE:COV) - February 11 at 2:51 AM
News IconAdhesion Barriers Market : Recent Industry Trends, Analysis and Forecast by 2020 (NYSE:COV) - February 11 at 2:51 AM logoGlobal Pressure Relief Devices Market to Exceed USD 2.85 Billion by 2020 (NYSE:COV) - February 8 at 9:48 PM logoGlobal Molecular Diagnostics Companies Market Research Report: The Top 600 in-Vitro Diagnostics Companies Worldwide; New Report Launched (NYSE:COV) - February 6 at 9:32 PM
News IconTracheal Tubes and Airway Products Market To Increase at Steady Growth Rate (NYSE:COV) - February 6 at 5:07 AM
News IconWorldwide Dialysis Products and Services Market by type & Growth with Forcast 2014-20. (NYSE:COV) - February 4 at 2:48 AM
News IconNorth America Acute Ischemic Stroke Diagnosis and Treatment Market Analysis,Growth and Forecasts(2016–2021) (NYSE:COV) - February 3 at 4:43 PM logoHypodermic Needles Market Will Generate New Growth Opportunities by 2021 (NYSE:COV) - February 3 at 4:43 PM logoIntracranial Pressure Monitors Market is Progressing Towards a Strong Growth by 2021 – Persistence Market Research Report (NYSE:COV) - February 3 at 4:43 PM
News IconGlobal Continuous Renal Replacement Therapy (CRRT) Market Analysis and Forecasts Research Report 2022 (NYSE:COV) - February 3 at 2:52 AM logoGynecology And Urodynamics Market - Positive Long-Term Growth Outlook 2019 (NYSE:COV) - February 2 at 9:49 PM logoAbsorbent and Packing Gauze Surgical Dressings Market (NYSE:COV) - February 1 at 9:48 PM
News IconResearch report covers the Disposable Incontinence Products Market 2016-2026 (NYSE:COV) - January 31 at 3:25 AM
News IconWeight Loss and Weight Management Global Market Trend, Research Approach, Data Analysis and Forecast to 2022 (NYSE:COV) - January 30 at 7:57 AM
News IconWho We Are. With more than 39,000 employees, Covidien operates in 150-plus countries and had 2014 revenue of $10.7 billion. (NYSE:COV) - January 30 at 7:57 AM logoGlobal Molecular Diagnostics Distributors Market Research Report: The Top 100 Distributors of Molecular Diagnostics Worldwide; New Report Launched (NYSE:COV) - January 28 at 3:56 AM logoScaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, … (NYSE:COV) - January 27 at 5:54 PM
News IconRecording Chart Paper Market Growth Forecast and Value Chain 2016-2026 (NYSE:COV) - January 27 at 5:54 PM logoVital Signs Monitoring Devices Market Estimated Poised to Rake US $9.4 Bn by 2025 (NYSE:COV) - January 25 at 5:35 PM
News IconObesity Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024 (NYSE:COV) - January 25 at 5:35 PM
News IconIntracranial Stents Market Is Expected To Continue Flourishing In Developed and Developing Regions Of World, 2021 – PMR Study (NYSE:COV) - January 24 at 2:52 AM logoGlobal Absorbent and Packing Gauze Surgical Dressings Market Trends By 2024 (NYSE:COV) - January 18 at 4:45 PM
News IconGlobal Absorbent and Packing Gauze Surgical Dressings Market: Rising Road Accidents to Benefit Market (NYSE:COV) - January 18 at 4:45 PM logoAbsorbent and Packing Gauze Surgical Dressings Market by Region Analysis 2024 (NYSE:COV) - January 18 at 4:45 PM logoPositive Developments Will Keep a Floor on Remote Patient Monitoring Devices Market (NYSE:COV) - January 16 at 9:29 PM logoJ&J gets partial win against Covidien in surgical patent case (NYSE:COV) - January 16 at 4:27 PM logoMedtronic sales surge as rise in U.S. surgeries drives demand (NYSE:COV) - January 16 at 4:27 PM logoIs There Another 25% Upside in Medtronic? (NYSE:COV) - January 16 at 4:27 PM logoBaxter names former Covidien chief José Almeida CEO (NYSE:COV) - January 16 at 4:27 PM


What is Covidien Ltd's stock symbol?

Covidien Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "COV."

How do I buy Covidien Ltd stock?

Shares of Covidien Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Covidien Ltd stock cost?

One share of Covidien Ltd stock can currently be purchased for approximately $108.07.

Covidien Ltd (NYSE:COV) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Covidien Ltd (NYSE:COV)

Earnings History Chart

Earnings by Quarter for Covidien Ltd (NYSE:COV)

Dividend History Chart

Dividend Payments by Quarter for Covidien Ltd (NYSE:COV)

Last Updated on 2/22/2017 by Staff